(Q35433650)

8 August 2017

1 reference

title

Risks connected with the use of conventional and genetically engineered vaccines (English)

1 reference

8 August 2017

T. G. Kimman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1413441

24 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1413441

24 September 2022

publication date

1 January 1992

1 reference

8 August 2017

1 reference

8 August 2017

volume

14

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

110-118

1 reference

Use of outer membrane protein PhoE as a carrier for the transport of a foreign antigenic determinant to the cell surface of Escherichia coli K-12.

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Ecology of orthopoxviruses and use of recombinant vaccinia vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Live Salmonella as vaccines and carriers of foreign antigenic determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Molecular mechanisms of nucleic acid integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Intragenic and intergenic recombination between temperature-sensitive mutants of vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Permanent brain damage and pertussis vaccination: is the end of the saga in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Vaccinia from recombinant virus expressing HIV genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Salmonella-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Human-rhesus reassortant rotavirus vaccines: safety and immunogenicity in adults, infants, and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

History, precedent, and progress in the development of mammalian cell culture systems for preparing vaccines: safety considerations revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Vaccinia virus: a suitable vehicle for recombinant vaccines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

A severe outbreak of respiratory tract disease associated with bovine respiratory syncytial virus probably enhanced by vaccination with modified live vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Contribution of single genes within the unique short region of Aujeszky's disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Comparative efficacy of three doses of the genetically engineered Aujeszky's disease virus vaccine strain 783 in pigs with maternal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Genetically engineered vaccines for control of Aujeszky's disease (pseudorabies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Biological evaluation of glycoproteins mapping to two distinct mRNAs within the BamHI fragment 7 of pseudorabies virus: expression of the coding regions by vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Stable Salmonella live vaccine strains with two or more attenuating mutations and any desired level of attenuation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Distemper encephalitis in pups after vaccination of the dam

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

The mucosal immune system: from fundamental concepts to vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Virus reactivation in pigs latently infected with a thymidine kinase negative vaccine strain of pseudorabies virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Structure, function, and intracellular processing of paramyxovirus membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Vaccinia virus: a tool for research and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Immune response to cholera toxin epitope inserted in Salmonella flagellin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Vaccine safety versus vaccine efficacy in mass immunisation programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

21 January 2018

Vaccination for Disease

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Enhanced recombination associated with the presence of insertion and deletion mutations in poxvirus-infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Biological control of wild animal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

New use of BCG for recombinant vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Comparison of the virulence of wild-type thymidine kinase (tk)-deficient and tk+ phenotypes of vaccinia virus recombinants after intranasal inoculation of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Recombinant fowlpox virus inducing protective immunity in non-avian species

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

The invasin protein of Yersinia enterocolitica: internalization of invasin-bearing bacteria by eukaryotic cells is associated with reorganization of the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

The induction of cytotoxic T-lymphocyte precursor cells by recombinant vaccinia virus expressing human papillomavirus type 16 L1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01652176.1992.9694344

10.1080/01652176.1992.9694344

21 January 2018

Identifiers

DOI

1 reference

8 August 2017

1 reference